Exploring the Cost-Effectiveness of Anti-Obesity Medications

This chapter examines a JAMA study on the health benefits and economic implications of anti-obesity drugs terzepatide and semaglutide. It addresses their effectiveness in combating obesity and related diseases while highlighting concerns over their high costs and the necessity for better insurance coverage.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.